We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GKOS icon
1251
Glaukos
GKOS
$10.6B
$55K ﹤0.01%
+696
New +$46.5K
VBTX
1252
DELISTED
Veritex Holdings
VBTX
$55K ﹤0.01%
2,260
FBIN icon
1253
Fortune Brands Innovations
FBIN
$6.06B
$54K ﹤0.01%
+1,329
New +$51K
NSA
1254
DELISTED
National Storage Affiliates Trust
NSA
$54K ﹤0.01%
1,886
+335
+22% +$9.29K
NUE icon
1255
Nucor
NUE
$62.1B
$54K ﹤0.01%
+925
New +$54.2K
RLJ icon
1256
RLJ Lodging Trust
RLJ
$1.69B
$54K ﹤0.01%
3,100
-1,392
-31% -$25.4K
BE icon
1257
Bloom Energy
BE
$64.6B
$53K ﹤0.01%
4,049
-27,792
-87% -$340K
OFG icon
1258
OFG Bancorp
OFG
$2.21B
$53K ﹤0.01%
+2,686
New +$52K
AIFU
1259
AIFU Inc
AIFU
$221M
$53K ﹤0.01%
5
-5
-50% -$49.4K
AC
1260
DELISTED
Associated Capital Group
AC
$52K ﹤0.01%
+1,331
New +$54.4K
EGP icon
1261
EastGroup Properties
EGP
$10.9B
$52K ﹤0.01%
466
-540
-54% -$56K
IMGN
1262
DELISTED
Immunogen Inc
IMGN
$52K ﹤0.01%
+19,047
New +$82.5K
GBX icon
1263
The Greenbrier Companies
GBX
$1.46B
$51K ﹤0.01%
+1,575
New +$62.7K
BOKF icon
1264
BOK Financial
BOKF
$8.74B
$50K ﹤0.01%
+610
New +$51.3K
PBI icon
1265
Pitney Bowes
PBI
$2.39B
$49K ﹤0.01%
7,100
-50,900
-88% -$352K
UNVR
1266
DELISTED
Univar Solutions Inc.
UNVR
$49K ﹤0.01%
+2,200
New +$47.4K
UROV
1267
DELISTED
Urovant Sciences Ltd.
UROV
$49K ﹤0.01%
+4,902
New +$50.3K
NTGN
1268
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$49K ﹤0.01%
+7,549
New +$39.5K
DF
1269
DELISTED
Dean Foods Company
DF
$49K ﹤0.01%
+16,300
New +$65.6K
GORO icon
1270
Goldgroup Mining Inc.
GORO
$191M
$48K ﹤0.01%
+12,292
New +$53.2K
ECHO
1271
DELISTED
Echo Global Logistics, Inc.
ECHO
$48K ﹤0.01%
1,944
-15,723
-89% -$371K
CEMI
1272
DELISTED
Chembio diagnostics, Inc.
CEMI
$48K ﹤0.01%
+8,612
New +$55.9K
BFS
1273
Saul Centers
BFS
$841M
$47K ﹤0.01%
+916
New +$48.6K
BKU icon
1274
Bankunited
BKU
$3.36B
$47K ﹤0.01%
+1,400
New +$48.3K
JYNT icon
1275
The Joint Corp
JYNT
$119M
$47K ﹤0.01%
+2,959
New +$31.3K

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.